WASHINGTON, June 27, 2024 /PRNewswire/ — The Heart Failure Society of America (HFSA) is a leading provider of education and professional development resources for clinicians treating patients with heart failure in the United States. To support these clinicians as they apply for initial Advanced Heart Failure and Transplant Cardiology (AHFTC) certification or re-certification with the America Board of Internal Medicine (ABIM), HFSA will host its AHFTC Board Certification Review July 12-14 in Chicago, Illinois at Loews Chicago O’Hare. This is the only in-person course to support clinicians in the AHFTC subspecialty taking place in 2024, to align with ABIM’s exam date on November 6, 2024.
The HFSA AHFTC Board Certification Review features 2.5 days of lectures, discussions and Q&As, with educational content built on the ABIM AHFTC certification exam blueprint and serving as an in-depth review of the key concepts, guidelines, and clinical practices outlined in the exam. Participants can earn up to 24.50 AMA PRA Category 1 Credits™. Several additional resources will provide participants with a toolbox they can use to study right up until test time.
Participants of the HFSA AHFTC Board Certification Review will receive these takeaway tools and resources:
The HFSA AHFTC Board Certification Review is conveniently being held in Chicago right near the airport, to allow for easy travel to and from the course, and to minimize clinicians’ time away from home and work.
For more information on the event, visit hfsa.org/boardreview2024.
About the Heart Failure Society of America
The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.
Media Contact: Laura Poko, 301-798-4493, ext. 226, lpoko@hfsa.org
SOURCE Heart Failure Society of America
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…